These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29348903)

  • 1. The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma.
    Inamoto T; Matsuyama H; Sakano S; Ibuki N; Takahara K; Komura K; Takai T; Tsujino T; Yoshikawa Y; Minami K; Nagao K; Inoue R; Azuma H
    Oncotarget; 2017 Dec; 8(68):113248-113257. PubMed ID: 29348903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Location Based Segmentation in Upper-Tract Urothelial Carcinoma Impacts on the Urothelial Recurrence-Free Survival: A Multi-Institutional Database Study.
    Inamoto T; Matsuyama H; Komura K; Ibuki N; Fujimoto K; Shiina H; Sakano S; Nagao K; Mastumoto H; Miyake M; Tatsumi Y; Yasumoto H; Azuma H
    Curr Urol; 2020 Dec; 14(4):183-190. PubMed ID: 33488336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
    Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
    Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Surgical Wait Time on Survival in Patients With Upper Urinary Tract Urothelial Carcinoma With Hydronephrosis.
    Zhao F; Qi N; Zhang C; Xue N; Li S; Zhou R; Chen Z; Yao R; Zhu H
    Front Oncol; 2021; 11():698594. PubMed ID: 34290988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Systemic Immune-Inflammation Index (SII) Increases the Prognostic Significance of Lymphovascular Invasion in Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
    Jan HC; Wu KY; Tai TY; Weng HY; Yang WH; Ou CH; Hu CY
    Cancer Manag Res; 2022; 14():3139-3149. PubMed ID: 36386553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non-urothelial recurrence and other clinical indicators.
    Takahara K; Inamoto T; Komura K; Watsuji T; Azuma H
    Oncol Lett; 2013 Oct; 6(4):1015-1020. PubMed ID: 24137456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
    Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial Carcinoma.
    Emamekhoo H; Dhillon P; Gopalakrishnan D; Elson P; Stephenson A; Magi-Galluzzi C; McKenney J; Harper H; Haber GP; Kaouk J; Lee B; Fergany A; Berglund R; Gong M; Stein R; Krishnamurthi V; Gilligan T; Ornstein M; Rini B; Garcia J; Grivas P
    Clin Genitourin Cancer; 2018 Aug; 16(4):e751-e760. PubMed ID: 29551583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum pre-albumin as an independent prognostic indicator in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy.
    Huang J; Wang Y; Yuan Y; Chen Y; Kong W; Chen H; Zhang J; Huang Y
    Oncotarget; 2017 May; 8(22):36772-36779. PubMed ID: 27906675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma.
    Youssef RF; Krabbe LM; Shariat SF; Lotan Y; Sagalowsky AI; Raman J; Wood CG; Weizer A; Roscigno M; Montorsi F; Bolenz C; Remzi M; Bensalah K; Kassouf W; Margulis V
    World J Urol; 2015 Dec; 33(12):1965-72. PubMed ID: 25957592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy.
    Song SH; Ye CH; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2863-2870. PubMed ID: 31501983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study.
    Qin C; Liang EL; Du ZY; Qiu XY; Tang G; Chen FR; Zhang B; Tian DW; Hu HL; Wu CL
    Medicine (Baltimore); 2017 May; 96(21):e6945. PubMed ID: 28538387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sex on prognosis of urothelial carcinoma: propensity score matching analysis.
    Choo MS; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2015 Apr; 13(2):e113-21. PubMed ID: 25456840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of preoperative systemic inflammation markers in localized upper tract urothelial cell carcinoma: a large, multicenter cohort analysis.
    Son S; Hwang EC; Jung SI; Kwon DD; Choi SH; Kwon TG; Noh JH; Kim MK; Seo IY; Kim CS; Kang SG; Cheon J; Ha HK; Jeong CW; Ku JH; Kwak C; Kim HH
    Minerva Urol Nefrol; 2018 Jun; 70(3):300-309. PubMed ID: 29381018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma.
    Meireles S; Dias N; Martins D; Dias C; Gonçalves M; Silva J; Silva CM; Oliveira PD; Soares P; Lopes JM
    Diagnostics (Basel); 2023 Jan; 13(1):. PubMed ID: 36611446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y; Li W; Wang D; Wu B
    World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2017 Jul; 35(7):458.e9-458.e15. PubMed ID: 28347659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.